General Information of Drug (ID: DM5VWOB)

Drug Name
Methylscopolamine Drug Info
Synonyms
Methscopolamine; methscopolamine; N-Methylscopolamine; N-methyl scopolamine; UNII-VDR09VTQ8U; VDR09VTQ8U; 13265-10-6; CHEMBL376897; (1r,2r,4s,5s)-7-{[(2s)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[33102,4]nonane; Metylskopolamin; 56552-70-6; 3-Oxa-9-azoniatricyclo[33102,4]nonane, 7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-, (1a,2b,4b,5a,7b); HSDB 5420; [3H]N-methylscopolamine; [3H]N-methyl scopolamine; [3H]NMS; Methyl scopolamine; 3C0
Therapeutic ClassAnticholinergic Agents
Cross-matching ID
PubChem CID
71183
ChEBI ID
CHEMBL135361
CAS Number
CAS 13265-10-6
TTD Drug ID
D0M6VK

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Thyroid hormone synthesis -1.65 4.37e-2 66/75 (88%) ADCY8;ALB;ADCY2;...
Histidine metabolism -1.66 3.97e-2 16/22 (72.73%) HAL;CNDP2;HDC;...
Epithelial cell signaling in Helicobacter pylori infect... -1.70 2.82e-2 62/70 (88.57%) CXCR2;EGFR;ATP6V1C1;...
NF-kappa B signaling pathway -1.73 2.09e-2 90/104 (86.54%) EDA;BTK;LCK;...
Insulin secretion -1.76 1.64e-2 75/86 (87.21%) ADCY8;KCNMB3;CCKAR;...
Cytokine-cytokine receptor interaction -1.78 1.36e-2 246/295 (83.39%) IL9;ACKR3;CSF1;...
Renin-angiotensin system -1.78 1.28e-2 20/23 (86.96%) CTSG;CTSA;ATP6AP2;...
Bile secretion -1.79 1.28e-2 68/90 (75.56%) ADCY8;UGT2B15;ADCY2;...
Pertussis -1.81 1.19e-2 64/76 (84.21%) NOS2;IRF3;LY96;...
Systemic lupus erythematosus -1.82 1.09e-2 45/135 (33.33%) FCGR2A;HLA-DRA;C1S;...
Legionellosis -1.83 9.62e-3 51/57 (89.47%) IL18;HSPD1;RAB1A;...
Mucin type O-glycan biosynthesis -1.84 1.05e-2 20/36 (55.56%) GCNT1;C1GALT1C1;GALNT11;...
Rheumatoid arthritis -1.85 1.03e-2 78/93 (83.87%) IL1B;ANGPT1;HLA-DRA;...
Amoebiasis -1.88 9.98e-3 99/102 (97.06%) PLCB4;ADCY1;IL6;...
TNF signaling pathway -1.88 1.12e-2 103/112 (91.96%) LIF;RIPK1;IL6;...
Proximal tubule bicarbonate reclamation -1.89 1.10e-2 21/23 (91.3%) CA2;ATP1B2;GLS;...
Carbohydrate digestion and absorption -1.89 1.28e-2 37/47 (78.72%) SLC2A5;SLC2A2;CACNA1D;...
Galactose metabolism -1.90 1.28e-2 26/31 (83.87%) HKDC1;MGAM;SI;...
Complement and coagulation cascades -1.97 0.00e+0 76/85 (89.41%) CFI;C4BPA;ITGB2;...
IL-17 signaling pathway -2.09 0.00e+0 84/94 (89.36%) CCL11;IL6;MAPK14;...
Viral protein interaction with cytokine and cytokine re... -2.18 0.00e+0 84/100 (84%) ACKR3;CSF1;CCR9;...
Other types of O-glycan biosynthesis -2.19 0.00e+0 29/47 (61.7%) B4GALT3;C1GALT1C1;GALNT11;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Bone marrow
Neuroblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SH-SY5Y CVCL_0019 Homo sapiens 0.04uM - 10uM 24H
SK-N-SH CVCL_0531 Homo sapiens 0.04uM - 10uM 24H